| |
| |
|
| Insider
Information: |
Hedley Mary Lynne |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
34,607 |
|
|
Indirect Shares
|
98 |
|
|
| Direct
Value |
$1,976,840 |
|
|
|
Indirect Value
|
$71,884 |
|
|
| Total
Shares |
34,705 |
|
|
| Total
Value |
$2,048,724 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Exec VP & Chief Scient... |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
|
New Abraxis Inc |
ABII |
Executive VP of Ops & ... |
2009-07-13 |
25,000 |
2009-07-13 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
President & COO, Direc... |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-05-28 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Director |
2018-06-20 |
3,700 |
2017-09-18 |
0 |
Premium* |
|
|
Veeva Systems Inc |
VEEV |
Director |
2024-03-01 |
4,430 |
2019-11-16 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Director |
2024-04-15 |
1,477 |
2024-04-15 |
98 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-04-15 |
4 |
A |
$750.77 |
$9,760 |
D/D |
13 |
1,477 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
1,464 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
302 |
4,430 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
1,449 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-01-16 |
4 |
A |
$634.57 |
$10,153 |
D/D |
16 |
1,437 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-28 |
4 |
AS |
$191.07 |
$8,025 |
D/D |
(42) |
4,128 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-27 |
4 |
AS |
$190.96 |
$7,829 |
D/D |
(41) |
4,170 |
0 |
% |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-12-18 |
4 |
A |
$579.76 |
$9,856 |
D/D |
17 |
1,421 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
303 |
4,211 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-11-20 |
4 |
A |
$597.60 |
$210,355 |
D/D |
352 |
1,403 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-10-16 |
4 |
A |
$616.64 |
$9,866 |
D/D |
16 |
1,051 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-09-18 |
4 |
A |
$571.28 |
$9,712 |
D/D |
17 |
1,035 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
302 |
3,908 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-08-21 |
4 |
A |
$550.50 |
$9,909 |
D/D |
18 |
1,017 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-07-17 |
4 |
A |
$447.14 |
$9,837 |
D/D |
22 |
999 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-07-13 |
4 |
AS |
$208.31 |
$28,747 |
D/D |
(138) |
3,606 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-07-12 |
4 |
AS |
$207.20 |
$19,062 |
D/D |
(92) |
3,744 |
0 |
% |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-06-20 |
4 |
A |
$451.95 |
$9,943 |
D/D |
22 |
977 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
326 |
3,836 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-05-15 |
4 |
A |
$434.51 |
$9,994 |
D/D |
23 |
953 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-04-17 |
4 |
A |
$372.35 |
$10,053 |
D/D |
27 |
930 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-03-20 |
4 |
A |
$333.60 |
$10,008 |
D/D |
30 |
655 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
327 |
3,510 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-02-21 |
4 |
A |
$327.51 |
$9,825 |
D/D |
30 |
623 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-01-17 |
4 |
A |
$357.74 |
$10,017 |
D/D |
28 |
593 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
